Institute of Cancer Sciences, University of Glasgow
Anthony Chalmers is Chair of Clinical Oncology at the University of Glasgow and Director of the CRUK Glasgow RadNet Centre.
In addition to his neuro-oncology clinical practice at the Beatson West of Scotland Cancer Centre, he leads the Translational Radiation Biology laboratory in the Institute for Cancer Sciences and is Chief Investigator of a series of early phase clinical trials in glioblastoma and mesothelioma.
His research aims to improve outcomes for cancer patients by combining radiotherapy with molecular targeted drugs, with particular focus on inhibitors of the DNA damage response.
From 2016 to April 2019 he was Chair of the NCRI’s CTRad, and was Founding Chair of the UK Radiotherapy-Drug Combinations Consortium (RaDCom) and the Scottish Radiotherapy Research Forum (ScoRRF).
He is a Board member of the European Association for Neuro-Oncology (EANO), sits on the Radiobiology Committee of the European Society for Radiation Oncology (ESTRO), and led successful bids for Glasgow to host EANO 2020 and ESTRO 2023.
In 2020 he was appointed to the Medical Research Council’s Molecular and Cellular Medicine Board.